Hypothalamic-Pituitary-Adrenal Axis Study in Participants With Perennial Allergic Rhinitis

- Perennial Female, Maleergic Rhinitis
- Completed

Study Title: Hypothalamic-Pituitary-Adrenal (HPA) Axis Study in Adult and Adolescent Subjects With Perennial Female, Maleergic Rhinitis (PAR)

Teva Identifier: BDP-AR-304

ClinicalTrials.gov Identifier: NCT01133626

Study Status: Completed

Trial Condition(s): Perennial Female, Maleergic Rhinitis

Interventions: Drug: Placebo Nasal Aerosol | Drug: Prednisone capsules | Drug: Placebo Prednisone Capsules | Drug: Beclomethasone dipropionate

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Child, Adult

Age Range: 12 Years to 45 Years

Trial Duration: 06/01/2010 - 09/01/2010

Phase: Phase 3

Study Type

Interventional